Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Changes in Stockholders Equity

v3.25.1
Consolidated Statements of Changes in Stockholders Equity - USD ($)
$ in Thousands
Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Non-Controlling Interests
Total
Balance at Dec. 31, 2022 $ 3 $ 7 $ 675,944 $ (634,233) $ 8,304 $ 50,025
Balance (in shares) at Dec. 31, 2022 3,427,138 7,366,283        
Stock-based compensation expense     17,029     17,029
Issuance of common stock related to equity plans (in shares)   224,690        
Issuance of stock for public offerings, net   $ 7 22,078     22,085
Issuance of stock for public offerings, net (in shares)   6,994,526        
Issuance of common stock for at-the-market offering, net     2,041     2,041
Issuance of common stock for at-the-market offering, net (in shares)   224,003        
Common shares issued for dividend on partner company's convertible preferred shares     266     266
Common shares issued for dividend on partner company's convertible preferred shares (in shares)   58,551        
Exercise of warrants for cash   $ 1 382     383
Exercise of warrants for cash (in shares)   225,000        
Partner company's at-the-market offering, net     4,620     4,620
Warrant issued in conjunction with debt     272     272
Partner companies' proceeds from options and warrants, net     59,956     59,956
Partner company's exercise of options for cash     121     121
Partner company's redemption of preferred shares     (400)     (400)
Issuance of common stock under partner company's ESPP     178     178
Preferred A dividends declared and paid     (8,032)     (8,032)
Partner company's dividends declared and paid     (736)     (736)
Issuance of partner company's common shares for research and development expenses     1,240     1,240
Deconsolidation/dissolution of partner companies         6,693 6,693
Non-controlling interest in subsidiaries     (57,563)   57,563  
Net loss attributable to non-controlling interest         (93,517) (93,517)
Net loss attributable to common stockholders       (60,637)   (60,637)
Balance at Dec. 31, 2023 $ 3 $ 15 717,396 (694,870) (20,957) 1,587
Balance (in shares) at Dec. 31, 2023 3,427,138 15,093,053        
Stock-based compensation expense     32,619     32,619
Issuance of common stock related to equity plans   $ 1 (1)      
Issuance of common stock related to equity plans (in shares)   582,323        
Issuance of stock for public offerings, net   $ 8 17,396     17,404
Issuance of stock for public offerings, net (in shares)   8,006,058        
Issuance of common stock under ESPP     99     99
Issuance of common stock under ESPP (in shares)   69,482        
Issuance of common stock for at-the-market offering, net   $ 2 3,732     3,734
Issuance of common stock for at-the-market offering, net (in shares)   1,957,331        
Common shares issued for dividend on partner company's convertible preferred shares     114     114
Common shares issued for dividend on partner company's convertible preferred shares (in shares)   64,747        
Common shares issued for exchange of partner company's convertible preferred shares   $ 2 3,406     3,408
Common shares issued for exchange of partner company's convertible preferred shares (in shares)   2,028,345        
Exercise of warrants for cash     181     181
Exercise of warrants for cash (in shares)   107,500        
Partner company's offering, net     28,852     28,852
Partner company's at-the-market offering, net     12,037     12,037
Warrant issued in conjunction with debt     1,104     1,104
Warrants issued in conjunction with exchange of partner company's convertible preferred shares     341     341
Issuance of common stock under partner company's ESPP     257     257
Preferred A dividends declared and paid     (4,016)     (4,016)
Partner company's dividends declared and paid     (694)     (694)
Exercise of partner company options and warrants for cash, net     22,184     22,184
Non-controlling interest in subsidiaries     (71,434)   71,434  
Net loss attributable to non-controlling interest         (74,858) (74,858)
Net loss attributable to common stockholders       (45,997)   (45,997)
Balance at Dec. 31, 2024 $ 3 $ 28 $ 763,573 $ (740,867) $ (24,381) $ (1,644)
Balance (in shares) at Dec. 31, 2024 3,427,138 27,908,839